Editorial commentary on "Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo"

Transl Androl Urol. 2020 Jun;9(3):1009-1012. doi: 10.21037/tau-2020-02.
No abstract available

Publication types

  • Editorial
  • Comment